Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-22Clinical Trial Results: Comparative Effectiveness of Family DSMES and Standard DSMES Among Diverse Populations [NA]
A completed comparative effectiveness trial evaluating Family DSMES versus Standard DSMES across diverse populations for type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2026-06-22Clinical Trial Results: Early Add-On Combination of GLP-1 Receptor Agonist and SGLT2 Inhibitor in People With Cardiovascular-Kidney-Metabolic Stage 2-3
Early add-on combination of GLP-1 receptor agonist and SGLT2 inhibitor studied in adults with cardiovascular-kidney-metabolic syndrome and r…
-
CLINICAL_TRIALS trial_result · 2026-06-18Clinical Trial Results: Personalized Dietary Management in Type 2 Diabetes [NA]
A completed clinical trial evaluating personalized dietary management for individuals with Type 2 Diabetes, with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-17Clinical Trial Results: Accuracy of Dexcom G6® and FreeStyle Libre® Sensors in Standardized Hypoxemia Conditions [NA]
A completed clinical trial evaluating the accuracy of Dexcom G6 and FreeStyle Libre sensors under standardized hypoxemia conditions in peopl…
-
CLINICAL_TRIALS trial_result · 2026-06-17Clinical Trial Results: (R33 Phase) DELISH Study: Diabetes Education to Lower Insulin, Sugars, and Hunger [NA]
A completed study evaluating diabetes education to lower insulin, sugars, and hunger in adults with type 2 diabetes; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-06-16Clinical Trial Results: Together Overcoming Diabetes [NA]
A completed clinical trial investigating Type 2 Diabetes with results posted in 2026; details are not specified here.
-
EMA approval · 2026-06-15EMA Authorised: Sitagliptin / Metformin hydrochloride Mylan (sitagliptin hydrochloride monohydrate;metformin hydrochloride) — Mylan Pharmaceuticals Limited
Authorised combination tablet of sitagliptin and metformin hydrochloride by Mylan Pharmaceuticals Limited for Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2026-06-15Clinical Trial Results: The Dietary Guidelines 3 Diets Study [NA]
Completed clinical trial study evaluating the Dietary Guidelines 3 Diets in adults with Type 2 Diabetes; results posted.
-
EMA approval · 2026-06-11EMA Authorised: Qtern (saxagliptin;dapagliflozin propanediol monohydrate) — Astra Zeneca AB
The EMA has authorised Qtern (saxagliptin and dapagliflozin propanediol monohydrate) for treatment of type 2 diabetes and related metabolic …
-
EMA approval · 2026-06-11EMA Authorised: Edistride (dapagliflozin propanediol monohydrate) — AstraZeneca AB
Edistride, containing dapagliflozin propanediol monohydrate, has been authorised for treatment in type 2 diabetes, systolic heart failure, h…
-
EMA approval · 2026-06-11EMA Authorised: Forxiga (dapagliflozin propanediol monohydrate) — AstraZeneca AB
Forxiga (dapagliflozin propanediol monohydrate) has been authorised for use in the European Medicines Agency, with indications including Typ…
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Update: A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both [Phase 3]
Phase 3 trial comparing CagriSema to tirzepatide for glycemic control and weight loss in adults with type 2 diabetes on_metformin and/or SGL…
-
EMA approval · 2026-06-08EMA Authorised: Jentadueto (linagliptin;metformin) — Boehringer Ingelheim International GmbH
European Medicines Agency authorizes Jentadueto (linagliptin/metformin) for type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Results: Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients [Phase 3]
Phase 3 trial evaluating SGLT2 inhibitors for efficacy, mechanisms, and safety in kidney transplant recipients, including those with post-tr…
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Update: Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients [Phase 3]
A Phase 3 trial evaluating efficacy, mechanisms, and safety of SGLT2 inhibitors in kidney transplant recipients, including post-transplant d…
-
EMA approval · 2026-06-05EMA Authorised: Ebymect (dapagliflozin propanediol monohydrate;metformin hydrochloride) — AstraZeneca AB
Authorised diabetes medicine combining dapagliflozin propanediol monohydrate with metformin hydrochloride for type 2 diabetes.
-
EMA approval · 2026-06-05EMA Authorised: Xigduo (metformin hydrochloride;dapagliflozin propanediol monohydrate) — AstraZeneca AB
Xigduo (metformin hydrochloride; dapagliflozin propanediol monohydrate) has been authorised for type 2 diabetes mellitus in the European Uni…
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4) [Phase 3]
Phase 3 study COMBINE 4 evaluated weekly IcoSema (insulin icodec + semaglutide) versus daily insulin glargine in Type 2 Diabetes; study comp…
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Results: Ertugliflozin: Cardioprotective Effects on Epicardial Fat [EARLY_Phase 1]
Early-phase trial assessing cardioprotective effects of ertugliflozin on epicardial fat in cardiovascular disease/atherosclerosis contexts; …
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Results: A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating weekly insulin icodec with semaglutide for type 2 diabetes; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial assessing weekly insulin icodec with semaglutide for reducing blood glucose in adults with type 2 diabetes has completed and…
-
CLINICAL_TRIALS research · 2026-04-29Clinical Trial Update: Lifestyle Interventions for Expectant Mothers (LIFE-Moms Phoenix) - Phoenix [Phase 3]
A Phase 3 clinical trial evaluating lifestyle interventions for expectant mothers to address obesity-related outcomes.
-
CLINICAL_TRIALS trial_result · 2026-04-28Clinical Trial Results: Intervention to Improve Diabetes Outcomes in Older African American Women With Multi-Caregiving Burden [NA]
Completed trial assessing an intervention to improve diabetes outcomes in older African American women with multi-caregiving burden.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight [Phase 3]
Phase 3 trial assessing semaglutide for weight loss in adults with obesity and type 2 diabetes completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Results: A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight [Phase 3]
Phase 3 trial results evaluating semaglutide for weight loss in adults with obesity and type 2 diabetes were completed and results posted.